Supriya Lifescience GM remanded in judicial custody over NDPS case
Supriya Lifescience has announced that its General Manager of Sales and Marketing will remain in judicial custody until July 17, 2026, due to an ongoing probe by the Customs Department under the NDPS Act. The firm clarified that the issue involves one specific export shipment and is presently being handled by the relevant court. The company further stated that it does not anticipate any significant effect on its financial status or daily business operations.